Physician profile
Katie E Peterson
NPI 1295176063
$849.57
in general payments reported to CMS, 2019-2025
18 companies · $89.17 in 2025
The $89.17 reported for 2025 was more than what a typical Advanced Practice Midwife provider received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $49.20 · 2022: $55.42 · 2023: $304 · 2024: $352 · 2025: $89.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.60 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $168.41 | 2023 | |
| Boston Scientific Corporation | $109.80 | 2024 | |
| Exeltis, USA INC. | $104.01 | 2022-2024 | Slynd |
| Hologic Sales and Service, LLC | $68.12 | 2023-2024 | Thinprep 2000 Processor, Third Wave, Affirm Prone Biopsy System |
| Millicent US INC | $60.86 | 2024-2025 | Femlyv, Intrarosa |
| Abbvie INC. | $56.84 | 2021-2024 | |
| Organon LLC | $36.31 | 2022-2024 | |
| Coopersurgical, INC. | $32.05 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Medtronic, INC. | $29.69 | 2024 | Interstim |
| Daiichi Sankyo INC. | $28.45 | 2023 | Injectafer |
| Ethicon US, LLC | $26.13 | 2025 | Evarrest, Vistaseal |
| Shield Therapeutics INC | $24.79 | 2024 | |
| Gilead Sciences, INC. | $24.15 | 2025 | |
| Pharmacosmos Therapeutics INC. | $18.93 | 2021 | |
| Mylan Pharmaceuticals INC. | $18.16 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $15.50 | 2023 | |
| Gynesonics, INC. | $13.72 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Pfizer INC. | $13.65 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.